key: cord-1001496-6iyd0wx6
authors: Nand, Mahesha; Maiti, Priyanka; Joshi, Tushar; Chandra, Subhash; Pande, Veena; Kuniyal, Jagdish Chandra; Ramakrishnan, Muthannan Andavar
title: Virtual screening of anti-HIV1 compounds against SARS-CoV-2: machine learning modeling, chemoinformatics and molecular dynamics simulation based analysis
date: 2020-11-23
journal: Sci Rep
DOI: 10.1038/s41598-020-77524-x
sha: 9fbf4a06040e536c54cc4ab8c2148a53b9cc7bd9
doc_id: 1001496
cord_uid: 6iyd0wx6

COVID-19 caused by the SARS-CoV-2 is a current global challenge and urgent discovery of potential drugs to combat this pandemic is a need of the hour. 3-chymotrypsin-like cysteine protease (3CLpro) enzyme is the vital molecular target against the SARS-CoV-2. Therefore, in the present study, 1528 anti-HIV1compounds were screened by sequence alignment between 3CLpro of SARS-CoV-2 and avian infectious bronchitis virus (avian coronavirus) followed by machine learning predictive model, drug-likeness screening and molecular docking, which resulted in 41 screened compounds. These 41 compounds were re-screened by deep learning model constructed considering the IC(50) values of known inhibitors which resulted in 22 hit compounds. Further, screening was done by structural activity relationship mapping which resulted in two structural clefts. Thereafter, functional group analysis was also done, where cluster 2 showed the presence of several essential functional groups having pharmacological importance. In the final stage, Cluster 2 compounds were re-docked with four different PDB structures of 3CLpro, and their depth interaction profile was analyzed followed by molecular dynamics simulation at 100 ns. Conclusively, 2 out of 1528 compounds were screened as potential hits against 3CLpro which could be further treated as an excellent drug against SARS-CoV-2.

Sequence similarity analysis, screening by the predictive model, dug-likeness and ADMET. In the first step, sequence alignment was carried out between the 3CL protease of the avian infectious bronchitis virus of the genus Gammacoronavirus (used in the training set of machine learning models) and the 3CLpro of SARS -CoV-2 using M-Coffee server. The results of M-Coffee depend on consistency considering incorrect alignments are less likely to be consistent than correct ones. Alignment accuracy was calculated with Column Score (CS) using the aln compare program. CS is the proportion of columns of residues correctly aligned between the test and reference alignments 15 . The score was 825 for the two given sequences and both sequences showed an excellent similarity which predicts that the protein used for the predictive model and another protein for molecular docking were similar (Fig. 2) . Both proteins share similar kinds of physicochemical parameters as evaluated by the ProtParam tool of ExPASy (Table 1) .

For the construction of the machine learning model, selected training set against 3CLpro of SARS coronavirus was evaluated by applying six different classification algorithms 16, 17 , viz., Decision Stump, Random Forest, Random Tree, J48 Pruned Tree, Naive Bayes, and Part. Decision Stump classifier was selected based on the results of auto ML and the rest classifies were evaluated as they were reported frequently in the drug discovery process. Out of 1395 compounds, the number of correctly classified instances (TP + TN) of the Decision stump classifier was 1392, whereas 1391were for J48 Pruned Tree, 1387 for Part, 1257 for Random Forest, 1284 for Naive Bayes and 1125 for Random Tree (Table 2 ). Based on the performance index, for all applied classifiers summarized in Fig. 3 , Decision Stump classifier was further selected for screening. The value of the Kappa statistics measure the consistency between the actual and the model classes, and the value 1 suggests an absolute agreement between AUC represents the probability that the active class predicted by the classifier models for a randomly selected compound will exceed that of a randomly selected non-active class. The area under the ROC curve will be 1 if there is no overlapping among the distributed classes. Out of 1528 antiviral compounds, 356 compounds were predicted as active by the model and considered for further study. Drug-like properties of compounds were calculated by analyzing its structural properties and applying certain drug-likeness rules. To get a potent drug-like compound, further screening was done by applying 5 drug-like rule filters viz., Lipinski's, Veber, Ghose, CMC-50, and BBB filter. According to Lipinski's "drug-like", molecules should have Log P ≤ 5, molecular weight ≤ 500, number of hydrogen bond acceptors ≤ 10, and number of hydrogen bond donors' ≤ 5. Veber rule predicts the oral bioavailability of potential drug candidates and it states a compound should have rotatable bonds < 12 and polar surface area < 140. Ghose includes the criteria like partition coefficient log P in − 0.4 to + 5.6 ranges, molar refractivity from 40 to 130, molecular weight from 180 to 480, and the number of atoms from 20 to 70 18 . CMC-50 predicts the drug-like indices of a molecule by comparing them with the Comprehensive Medicinal Chemistry (CMC) database and states that a compound should have logP (ALOGP) between 1.3 and 4.1, molar refractivity (AMR) between 70 and 110, molecular weight (MW) between 230 and 390, and the number of atoms (nAT) between 30 and 55 19 . BBB filter predicts the permeability of the Blood-Brain Barrier. 84 efficient drug-like compounds that were screened by all the above filters were considered further screening (Supplementary Table S1 ).

To conduct a molecular docking, a grid of 25 Å was generated over the co-crystallized peptide-like inhibitor (X77) and small-molecule inhibitor (PDB ID: Table S2 ). Further, a deep learning model was constructed to screen the compounds to get compounds with better IC 50 value than the reference inhibitor used in molecular docking. The model was evaluated with a range of statistical parameters and good performance was observed with R2 value (0.85), MSE (7.80), and RMSE (2.79) (Fig. 5 ). 22 compounds were screened by the model having a score higher than the reference molecule (4.29) (Supplementary Table S3 ). SAR and functional group analysis. Thereafter, screened 22 compounds were further analyzed (considering their maximum sub-structural fragments) by chemical space mapping in CheS-Mapper software. All the compounds were analyzed by considering 413 chemical properties. Along with the above 22 compounds, 12 established inhibitors of 3CLpro obtained from PDB (Supplementary Table S4 ) were also analyzed for their common structural fragments. The 34 compounds were mapped in two distinct clusters -16 in cluster 1 and 18 in cluster 2. As such no common fragment was found in cluster 1, compounds in cluster 2 (5 compounds were established inhibitors and 13 compounds were screened by the current study) were considered for further analyses. 61 of 413 features having equal value for each compound were not included for mapping. In cluster 2, out of 18, 5 compounds were established inhibitors and 13 compounds were screened by the current study. Thereafter, the group frequency of some vital functional groups was analyzed for both the established inhibitors and the screened compounds (Supplementary Table S5 ). Among them, four comparable functional groups were found to have a significant presence in reference inhibitors as well as in screened compounds (Fig. 6 ). The first group was R2NH (amine), followed by tertiary amines (R3N), rings, and aromatic. Amines are considered weak bases and most of the drugs have amine as functional groups as they get easily ionized in slightly acidic and alkaline pH of the gut as well as in blood. They can also easily equilibrate between the ionized and non-ionized forms. They can cross the cell membrane in non-ionized forms, whereas the ionized form allows good water solubility that ultimately promotes strong protein-ligand interaction 20 . The screened compounds contain a high frequency of amines (1.18) than the reference inhibitors (0.83). Secondary amines have N-H groups and act as a hydrogen bond donor that facilitates strong binding of the compound with the target protein 21 . The presence of secondary amine was more frequent in the screened compounds (0.92) comparing with the reference inhibitors (0.54). Further, docking experiment was again conducted to check the binding potential of screened compounds of cluster 2 with all other four reference PDB structures (5r81, 5r82, 5r84, and 5rec) of 3CLpro. All the screened compounds showed higher binding potential in terms of binding energy, compared with the reference ligand (Supplementary Table S6 ). Interaction profiles of all the docked complexes with lower RSMD values were further checked. The hit map profiles of all the interactions (hydrophobic, hydrogen, pie, halogen and base stacking (Supplementary Table S7 ) showed that the ligand number hit-9, hit-10, and hit-11 showed higher binding potential with 3CLpro (Fig. 7) . From the above experiments, 3 out of 1528 compounds were considered as the potential hits against 3CLpro.

In the final step, Molecular Dynamics (MD) simulations were carried out for 100 ns to analyzing the structural changes observed during the course of inhibition 22 . Analysis of Root Mean Square Deviation (RMSD) shows all complexes are stable in 100 ns simulation. The average value of RMSD is 0.62 nm (green) for hit 9, 0.43 nm (blue) for hit 10, respectively as compared to the reference 0.17 nm (red). The Root Mean Square Fluctuation (RMSF) indicates occurrence of local changes along with the protein chain residues at specific temperature and pressure. RMSF shows the fluctuation of 0.2 nm in amino acids during the 100 ns trajectory period. Hydrogen bonds play a critical role in binding a ligand to a receptor, which affects drug specificity, metabolization, and adsorption of a drug. Therefore, the total numbers of hydrogen bonds were estimated for 100 ns simulation period. Around 4 hydrogen bonds were observed in the reference while hit 9 and hit10 showed 3 and 4, respectively. Further, the average value of SASA were 147.84 ± 1.99 nm 2 (green), 147.64 ± 1.77 nm 2 (blue) and 149.29 ± 2.17 nm 2 (red) for hit 9, hit 10, and reference these values show the extent of the conformational changes occurring during the interaction. The results showed the assessable surface area www.nature.com/scientificreports/ of screened compounds similar to the reference compound in water system which indicates the equivalent stability of hits compounds as compared to reference (Fig. 8 ).

Since 3CLpro is involved in the replication of SARS-CoV-2, inhibition of its function may be an effective strategy to control SARS-CoV-2 infection. In this regard, experimentally validated HIV protease inhibitors could be tested against SARS-CoV-2 10 by targeting 3CLpro function. HIV protease inhibitors like Lopinavir/ritonavir are reported effective against SARS-CoV 3CLpro 14 . Since both SARS-CoV-2 and HIV belong to the positive sense RNA virus group it is logical to apply the same principle for SARS-CoV-2 also. In the genomic structure of SARS-CoV-2, ORF1a and ORF1b occupy two-thirds of the genomes at the 5′ end. ORF1a and ORF1b are translated into two polyproteins 1a and 1b (pp1a and pp1ab) through a ribosomal frame shift sequence. These polyproteins are further processed by 3CLpro and PLpro proteases to produce nonstructural proteins. Thus, blocking 3CLpro is a promising approach that will ultimately stop viral replication machinery. Some reported virtually screened compounds against SARS-CoV-2, 3CLpro are Velpatasvir, Ledipasvir, Prulifloxacin, Bictegravir, Nelfinavir, and Tegobuvi, Pimozide, Ebastine, Rupintrivir, Bepridil, Sertaconazole, Rimonabant, and Oxiconazole 23 . From current work, two potent inhibitors (CID 2301119, 948801, 859639), have been screened against 3CLpro of SARS-CoV-2 by in silico screening. Above identified inhibitors should have strong antiviral property against SARS-CoV-2, as they were screened by a comprehensive machine learning model development against 3CLpro using the dataset of avian Infectious Bronchitis Virus (IBV) (avian coronavirus). Protein sequences of 3CLpro of both viruses show on sequence similarity analysis which indicates similar molecular function. Our machine learning model had a ROC area of 0.99 which reflects high accuracy of the model in terms of both sensitivity and specificity. All the inhibitors were also screened with excellent drug-like and ADMET profiles by five drugslike filters (Lipinski's, Veber, Ghose, CMC-50, and BBB filter). The two screened compounds also show strong binding potential with 3CLpro and share common structural clefts with the established inhibitors. They have a high frequency of antiviral functional groups like R2NH (amine), followed by tertiary amines (R3N) , rings, and aromatic. During the MD simulation of 100 ns, only hit 9 and hit 10 showed high RMSD, RMSF values that reflect www.nature.com/scientificreports/ their stability profile during the course of inhibition. Their hydrogen bonding profile showed that they can bind very tightly with 3CLpro whereas the SASA analysis results showed that they have least exposed surface area comparing with the reference ligand which indicates their stability as complex with 3CLpro. The first screened hit compound (hit-9 in Fig. 7 ) is 4-{[5-(2-Nitrophenyl)-2-furyl] methylene}-3-phenyl-5(4H)-isoxazolone (CID-230119). We found a total of 73 PubChem bioassays about this compound showing activity against viruses Dengue virus-2 16,681-PDK53 and Macacamulatta polyomavirus1 24 . Previously, Phenyl oxazole compounds have been reported against 3CLpro as these aromatic moieties can bind to S1 or S2 site of SARS protease by forming H-bonds and hydrophobic interactions. The compound has also binding potential with His-41, of His41-Cys145 dyad of 3CLpro which is critical for inhibiting the catalytic activity of the enzyme. The second screened hit compound (hit-10) is 4-Chloro-N-(1-methyl-1H-benzimidazole-5-yl) benzamide (CID-948801). It has been reported as an active compound in 33 PubChem bioassays 25 . The compound was found to have hydrogen bonds with Arg298, a critical residue for maintaining the dimer structure of the enzyme and also regulates the catalytic activity. All the screened compounds have been reported as active against 3C-like protease of IBV, which reflects the strong possibilities they can be potential hits inhibitors against 3C-like protease of SARS-CoV-2. Therefore, the two newly identified inhibitors could serve as promising drug candidates against SARS-CoV-2.

Sequence similarity analysis. Sequence alignment analysis was done to evaluate the similarity between the 3CL protease of avian infectious bronchitis virus (IBV) that has been used in the training set of machine learning models and the 3CLpro of SARS CoV-2 that will be used for the molecular docking process. M-Coffee extension of T-Coffee multiple sequence alignments (MSA) server was used for this purpose. This server outperforms on reference datasets: HOMSTRAD, Prefab, and Balibase. Physicochemical parameters of proteins including isoelectric point, instability index, grand average of hydropathicity (GRAVY), amino acids, and atomic compositions were investigated using the ProtParam tool of ExPASy 15 .

Dataset. In the present work, the compounds from a QFRET-based primary biochemical high throughput screening assay (AID-1706) against 3CLPro of SARS coronavirus 16 are used as a training set. As large number of datasets is not available against 3CLpro of SARS CoV-2, the present dataset of avian infectious bronchitis virus (IBV) 3CLpro is selected for construction of the machine learning model. In this bioassay, the sum of two values was considered as cut-off parameters for classifying the compounds, viz., (i) the average percent inhibition of all compounds tested, and (ii) three times their standard deviation. In PubChem bioassays, activity score is assigned as a normalized score between 0 and 100 where the most active result rows have scores closer to 100 and inactive www.nature.com/scientificreports/ closer to 0. In the present bioassay, activity score between 0 and 15 were classified as inactive and between 25 and 100 as active. 405 active compounds and 1000 inactive compounds were considered for generating the QSAR model. Further, 1528 anti-HIV1 compounds were selected for screening as a test set from NCI AID antiviral assay (AID-179) 26 . From this bioassay, compounds that provide at least 50% protection by inhibiting the HIV1 infected human CEM cells were considered.

Descriptor calculation and dataset pre-processing. The entire compound collection of training and the test set was converted into a 3D-standard data format (3D-SDF) to simplify the molecular-input line-entry system (SMILES) format by using O'babel software 27 . Further, all compounds were introduced to chemical descriptor calculation using PaDel software. Initially, a total of 2382 descriptors were extracted, which included 1D, 2D, and fingerprint features. The entire dataset was processed before building the model in WEKA software 28 . Several functions in WEKA like Correlation, Attribute, Eval, and Replace Missing Values were considered for the feature selection process. Feature selection is necessary to make a better performing predictive model.

A machine learning model was developed using the training set compounds applying six different classifiers with a tenfold cross-validation approach. Combinations of manual and automatic methods were applied for the selection of appropriate classifier. 5 ML classifiers that are normally used for drug development were applied on the training set, viz., Random Forest, Random Tree, J48 Pruned Tree, Naive Bayes, and Part. Random forest classifier acts as tree predictors, where every single tree differs on the values of a random vector and with the identical distribution for each tree in the forest. J48 algorithm built a C4.5 decision tree and each time when it executes, an instance of the class is created by allocating memory for constructing and storing the decision tree classifier. PART classifier generally decreases the class of existing classified data to just a single class, and pick up the data using any information from other classes. Random Tree is a supervised classifier that shots the input feature vector and classifies it with each tree in the forest 29 . Finally, it outputs the class label that has obtained the majority of "votes". Auto Machine Learning (AutoML) method was also applied that allows automatic selection of the most accurate and comprehensible ML algorithm during the model development 30 . The decision stump algorithm was selected by the AutoML function. The one-level decision tree was made by the decision stump algorithm in which the root level split based on a specific attribute. The Area under Curve (AUC) value was also evaluated which denotes the probability that a classifier will rank a randomly chosen active compound higher than a randomly chosen inactive compound 31 .

Dug-likeness and ADMET screening. Further, all the screened compounds were filtered by evaluating their Drug-like and ADMET properties using the DruLiTo software 32 . Five filters were selected for this purpose, viz., Lipinski's, Veber, Ghose, CMC-50, and BBB filter. Molecular docking. The 3D structure of SARS-CoV-2 main protease was retrieved from Brookhaven Protein Data Bank with PDB ID-6W63. The receptor was bound with native ligand X77, a non-covalent inhibitor. The grid parameters of native ligand were calculated by using Chimera 1.8. PyRx graphic user interface (GUI) version 0.8.was used for further screening by docking using AutoDockVina program 33 Screening by deep learning model. Additional screening was done by a deep learning predictive model using deep learning online server 34 . The dataset CHEMBL3927, having SARS coronavirus 3C-like proteinase inhibitors with IC 50 values was used as a training set 35, 36 . Regression analysis was considered for building the model and its efficacy was measured in terms of R squared (R 2 ), Mean squared error (MSE), Root MSE (RMSE), and Mean absolute error (MAE).

Structural activity relationship (SAR) mapping and functional group analysis. The final screening was carried out by SAR mapping using CheS-Mapper software protocols 37 . Here, all the screened compounds along with the reference ligand were mapped by clustering and multi-dimensional scaling through chemical space mapping. The Cascade K-Means algorithm of WEKA was used as a classifier, and feature selection was done by Principal Component Analysis. Finally, the maximum sub-structural fragment aligner algorithm was used for final alignment. The functional group's frequencies of all compounds were analyzed by R (version 3.4.3) under the library of "ChemmineR" 38 . Further, another docking experiment was also conducted to check the binding potential of the screened compounds with 4 different PDB structures of 3 CLpro, namely, 5r81, 5r82, 5r84, and 5rec and their interaction profile was checked by Lig profiler.

The best-scored poses of screened complexes were further analyzed for binding stability by conducting MD simulations for 100 ns trajectory period at a constant temperature of 300 K using the GROMACS 18.7 software package. All the MD simulations were fabricated as an orthorhombic grid box (10 Å × 10 Å × 10 Å buffer) followed by the addition of Transferable Intermolecular Potential 3 Point (TIP3P) water molecules. Systems were neutralized by the addition of 4 NA + ions using the steepest descent algorithm with the Verlet cut-off scheme with maximum force 10 kJ/mol. Further, the equilibration step was carried out on NVT (constant volume) as well as NPT (constant pressure) for 100 ps time. Further, MD simulation was conducted for a 100 ns time at a constant temperature of 300 K and a constant pressure of 1 atm with a time step of 2 fs using the Parrinello-Rahman method. The generated trajectories were used to analyze each complex's behavior to access the stability of the system in the explicit water environment. The deviations of the complex system were analyzed by calculating Root Mean Square Deviation (RMSD), Root Mean Square Fluctuation (RMSF), hydrogen bonds, Solvent Accessible Surface Area (SASA) 39 .

Initial X-ray structures are available at Protein Data Bank (https ://www.rcsb.org/). Datsets used from different bioassays are available at PubChem (https ://pubch em.ncbi.nlm.nih.gov/). All other data are available either in the main text or as supplementary materials. 

The species severe acute respiratory syndrome-related Coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Identification of novel compounds against three targets of SARS CoV2 coronavirus by combined virtual screening and supervised machine learning

A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease

Structural basis of SARS-CoV-2 3CLproand anti-COVID-19 drug discovery from medicinal plants

Coronavirus puts drug repurposing on the fast track

Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases

Features, evaluation and treatment coronavirus (COVID-19)

RNA Viruses: RNA roles in pathogenesis, co-replication and viral load

CoV-2: An emerging coronavirus that causes a global threat

Anti-HIV drug repurposing against SARS-CoV-2

Old drugs as lead compounds for a new disease binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs

Expanding the frontiers of existing antiviral drugs: possible effects of HIV-1 protease inhibitors against SARS and avian influenza

HIV protease inhibitor nelfinavir inhibits replicationof SARS-associated coronavirus

Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV3CL(pro) inhibitors

combining multiple sequence alignment methods with T-Coffee

Predictive model assisted in silicoscreening of anti-lung cancer activity of compounds from lichen source

A Comparative Analysis of Data Mining Techniques on Breast Cancer Diagnosis Data using WEKA Toolbox

Quantifying the chemical beauty of drugs

D Properties user's manual. Software for Physicochemical properties and drug-like indices Drug-like indices

An introduction to medicinal chemistry. Department of Chemistry

Structure, mechanism, and synthesis

Designing novel possible kinase inhibitor derivatives as therapeutics against Mycobacterium tuberculosis: An in silico study

Targeting the dimerization of the main protease of coronaviruses: a potential broad-spectrum therapeutic strategy

AID 179 -NCI AIDS Antiviral Assay -PubChem

Open Babel: an open chemical toolbox

Data mining for classification of power quality problems using WEKA and the effect of attributes on classification accuracy

Meta-QSAR: a large-scale application of meta-learning to drug design and discovery

Virtual screening of drug likeness using tree based ensemble classifier

Predictive classifier models built from natural products with antimalarial bioactivity using machine learning approach

Department of Pharmaco informatics, National Institute of Pharmaceutical Education and

Virtual screening as a tool to discover new β-haematin inhibitors with activity against malaria parasites

Deep screening: a deep learning-based screening web server for accelerating drug discovery

Development of a simple, interpretable and easily transferable QSAR model for quick screening antiviral databases in search of novel 3C-like protease (3CLpro) enzyme inhibitors against SARS-CoV diseases

Predictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease

Chemical space mapping and visualization in3D

Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care

The authors acknowledge with thanks to the Director, G.B. Pant National Institute of Himalayan Environment, Kosi-Katarmal, Almora, Uttarakhand-263643, for providing facilities in the Institute which could make the present work possible.

M.N. conducted the machine learning and molecular docking experiments and planned outline of this research, P.M. generated the idea, carried out the SAR analysis and wrote the manuscript, T.J. carried the functional group analysis, Simulation M.A.R., S.C., V.P. and J.C.K. critically reviewed and guided in the idea generation.

The authors declare no competing interests.

Supplementary information is available for this paper at https ://doi.org/10.1038/s4159 8-020-77524 -x.Correspondence and requests for materials should be addressed to P.M., S.C. or M.A.R.Reprints and permissions information is available at www.nature.com/reprints.Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.